about
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controlsHPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha.Clinical variability of respiratory pulmonary hypertension: implications for diagnosis and management.And the patient said: "let me be able to breathe and dream".Smoking Habit in Severe Obese after bariatric proceduresObstructive Sleep Apnea, Hypertension, and Their Additive Effects on Atherosclerosis.Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency.An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis.Titration effectiveness of two autoadjustable continuous positive airway pressure devices driven by different algorithms in patients with obstructive sleep apnoea.Epileptic seizures cause extended postictal cerebral vascular dysfunction that is prevented by HO-1 overexpression.Home unattended portable monitoring and automatic CPAP titration in patients with high risk for moderate to severe obstructive sleep apnea.An electronic nose discriminates exhaled breath of patients with untreated pulmonary sarcoidosis from controls.Lack of association between OSAS and hypothyroidism.Early and late failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute exacerbation.Evaluation of a transcutaneous carbon dioxide monitor in severe obesity.End points for pulmonary arterial hypertension: a way backward.Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea.An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea.The Epworth Sleepiness Scale: conventional self vs physician administration.Influence of obstructive sleep apnea on endothelial function in obese patients.Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma?Is there a correlation between OSAS duration/severity and carotid intima-media thickness?Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: Preliminary results.Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients.Predictive equations for CPAP titration in OSAS patients.Excessive daytime sleepiness in women without OSA.Severe obstructive sleep apnoea exacerbates the microvascular impairment in very mild hypertensives.Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome?CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasisNuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistanceExhaled breath condensate as matrix for toluene detection: a preliminary studyRecurrent pulmonary embolism due to echinococcosis secondary to hepatic surgery for hydatid cystsSniff nasal pressure is a sensitive marker of poor outcome in amyotrophic lateral sclerosisThe importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis
P50
Q28248282-A06CD0CC-D3B7-4EBE-B2B7-BC535E86D670Q33379617-1ACBE43B-AA39-4C9B-A1F3-C29E242E1B27Q34447628-8753432E-E666-4874-AB6E-64EB82141562Q35542017-ABEE85AF-7AE5-4755-B4A7-1D5E95B607D1Q35899056-268A0A58-9185-457E-9D2E-54FE42EA87BAQ36368997-34F07320-6D30-436D-BC4B-D0CB65DF3B3CQ37140443-3344F4F5-7D56-4743-896A-D05F4451B1CAQ40039324-9902AA32-7400-4CD8-B10F-84D4516989C5Q43828824-0A881C7C-FD2B-45BB-AFB8-2DCDA5EEB495Q44490778-8EAE4E0F-942B-401D-8FED-3F65B4999DB5Q45244980-FEC5FDB3-5A38-4ED0-9656-DD1CD9D69FE9Q45789877-AAE9910E-F4C1-495C-9657-D2D21DA20EFDQ45868312-722FA50F-AC8C-41D2-98ED-4CEC231AEC55Q45908527-6E61877F-749F-49D7-994A-CB573D364394Q47781917-D1F212F9-3BF4-4C1E-914A-B58FEA8E3E15Q47819228-73555389-DCAE-41DC-B7FF-585DD6AFFDCBQ47903139-5C4B2AEB-DE5E-4085-AA48-AA46BA52F939Q47935780-0B6E7C2B-5986-4C5B-A088-FDD40F3FC0B2Q47979241-9F44D577-7443-448B-9205-6183BCAEAE9DQ48191258-C4FC2F79-F70A-40A4-8D57-FFA0DA671E56Q48239905-CDC95699-07A4-4A4B-AA89-7F186E0800C6Q48240955-D2CE9B2D-0128-4FB4-9562-7F5CFA077511Q48259497-D1BB8DA7-78B7-4280-B171-EEA25ED372E4Q48293676-C51E7060-9BFE-4E5E-A7FD-1B542DB25CEBQ48314979-3D365254-35A1-47E2-8B96-1ECC10AC9941Q48323165-D8C610C5-9236-4648-A9A0-6D685D4D9CE9Q48392023-C74BDC47-75CA-4CF5-850D-52AABC27094BQ48421731-D71300D7-EEE6-441D-AC03-10A3F01A9376Q48433721-98EA7F15-5274-4321-A000-2FCA07DD7BE5Q61696162-A12349FD-CE83-40AD-A90D-286E691A1AE6Q82928913-045D39A9-F230-4FDD-AD1C-4190DC3852AAQ83946117-56C0B283-6FF0-4FE4-B2D9-E0F2D1308658Q84998803-05703FD9-6229-47D4-9879-A24A6CC1039BQ86522622-4536DFE7-9657-4B81-A32C-DB2CAF379AF9Q96223015-F4E5334D-0274-439A-AE92-C37CE628310A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pierluigi Carratù
@ast
Pierluigi Carratù
@en
Pierluigi Carratù
@es
Pierluigi Carratù
@nl
Pierluigi Carratù
@sl
type
label
Pierluigi Carratù
@ast
Pierluigi Carratù
@en
Pierluigi Carratù
@es
Pierluigi Carratù
@nl
Pierluigi Carratù
@sl
prefLabel
Pierluigi Carratù
@ast
Pierluigi Carratù
@en
Pierluigi Carratù
@es
Pierluigi Carratù
@nl
Pierluigi Carratù
@sl
P106
P1153
6601997512
P21
P31
P496
0000-0003-2208-6215